Latest Breaking News On - Glomerulonephritis center at massachusetts - Page 1 : comparemela.com

A single-center study found that using B-cell levels to determine when to infuse rituximab reduced relapses in patients antineutrophil cytoplasmic antibody vasculitis.

United statesJohnl nilesRobert hyllandGlomerulonephritis center at massachusettsHarvard medical schoolMichigan state university college of osteopathic medicineGlomerulonephritis centerMassachusetts general hospitalMedscape medicalMichigan state university collegeOsteopathic medicineBiologic therapyAntineoplastic drugNti cancer agentsMonoclonal antibodyCovid 19